Clinical trial
Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV…
NCT00019240 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019240 |
|---|---|
| Title | Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection |
| Official title | PHASE II PROTOCOL WITH LABORATORY CORRELATES OF 1-[(S)-3-HYDROXY-2-(PHOSPHOMETHOXY)PROPYL]CYTOSINE DIHYDRATE(CIDOFOVIR) IN PATIENTS WITH KAPOSI'S SARCOMA (KS) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | cidofovir |
| Start date | Nov 1, 1996 |
| Completion | Apr 1, 2004 |
| First posted | Apr 21, 2004 |
| Last update posted | Jun 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: